Nazmul Islam Abir

Nazmul Islam Abir Executive, Quality Compliance Ltd. M Pharm. If You Helped! Pray For Me🤲 I am a person who is positive about every aspect of life.

There are many things I like to do, to see, and to experience. I like to read, I like to write; I like to think, I like to dream; I like to talk, I like to listen.

‘āĻâ€™, ‘āĻŦāĻŋ’ āĻāĻŦāĻ‚ ‘āϏāĻŋ’ āĻ•ā§āϝāĻžāϟāĻžāĻ—āϰāĻŋāϰ āϰ⧇āϜāĻŋāĻ¸ā§āĻŸā§āϰ⧇āĻļāύ⧇āϰ āφāĻŦ⧇āĻĻāύ⧇āϰ āĻ•ā§āώ⧇āĻ¤ā§āϰ⧇ āϏāĻ‚āĻļā§āϞāĻŋāĻˇā§āϟ āĻ•āĻžāĻ—āϜāĻĒāĻ¤ā§āϰāĻžāĻĻāĻŋāϰ āϏāĻ¤ā§āϝāĻžā§Ÿāύ⧇āϰ āĻļāĻ°ā§āϤ āĻŦāĻžāϤāĻŋāϞ āĻ•āϰāĻž āĻšā§Ÿā§‡āϛ⧇āĨ¤
24/07/2025

‘āĻâ€™, ‘āĻŦāĻŋ’ āĻāĻŦāĻ‚ ‘āϏāĻŋ’ āĻ•ā§āϝāĻžāϟāĻžāĻ—āϰāĻŋāϰ āϰ⧇āϜāĻŋāĻ¸ā§āĻŸā§āϰ⧇āĻļāύ⧇āϰ āφāĻŦ⧇āĻĻāύ⧇āϰ āĻ•ā§āώ⧇āĻ¤ā§āϰ⧇ āϏāĻ‚āĻļā§āϞāĻŋāĻˇā§āϟ āĻ•āĻžāĻ—āϜāĻĒāĻ¤ā§āϰāĻžāĻĻāĻŋāϰ āϏāĻ¤ā§āϝāĻžā§Ÿāύ⧇āϰ āĻļāĻ°ā§āϤ āĻŦāĻžāϤāĻŋāϞ āĻ•āϰāĻž āĻšā§Ÿā§‡āϛ⧇āĨ¤

"Aristopharma’s Excellence is now recognized Globally – EU GMP Approved!"We are tremendously proud to share this Great m...
18/07/2025

"Aristopharma’s Excellence is now recognized Globally – EU GMP Approved!"

We are tremendously proud to share this Great milestone that Aristopharma’s ophthalmic manufacturing facility is now EU GMP (European Union Good Manufacturing Practice) approved-a key regulatory standard recognized globally for pharmaceutical manufacturing excellence.

This milestone is more than a compliance achievement—it’s a reflection of our vision to lead with integrity, operate with precision, and our unwavering commitment to global standards of quality, safety, excellence, and compliance protocols.

We extend our deepest gratitude to all doctors and patrons of Aristopharma for this glorious achievement.

Aristopharma (Unit 2: Gachha) Opthalmic Facility (largest Opthalmic Facility in Bangladesh)  got the prestigious EU GMP ...
15/07/2025

Aristopharma (Unit 2: Gachha) Opthalmic Facility (largest Opthalmic Facility in Bangladesh) got the prestigious EU GMP Certification.

Congratulations Opthalmic Team. đŸ’ĨđŸ’Ĩ

The theme for World Pharmacists Day 2025, is “Think Health, Think Pharmacist.” Pharmacists deliver vital care to communi...
07/07/2025

The theme for World Pharmacists Day 2025, is “Think Health, Think Pharmacist.”

Pharmacists deliver vital care to communities every day — let’s use this moment to showcase our impact and call for greater investment in our role, now and for the future.

āĻŦāĻžāĻ‚āϞāĻžāĻĻ⧇āĻļ āĻĢāĻžāĻ°ā§āĻŽā§‡āϏ⧀ āĻ•āĻžāωāĻ¨ā§āϏāĻŋāϞ⧇āϰ 'āĻ', 'āĻŦāĻŋ' āĻāĻŦāĻ‚ 'āϏāĻŋ' āĻ•ā§āϝāĻžāϟāĻžāĻ—āϰāĻŋāϰ āϰ⧇āϜāĻŋāĻ¸ā§āĻŸā§āϰ⧇āĻļāύ āϏāĻ‚āĻ•ā§āϰāĻžāĻ¨ā§āϤ āĻ•āĻžāĻ°ā§āϝāĻ•ā§āϰāĻŽā§‡āϰ āĻšāĻžāϞāύāĻžāĻ—āĻžāĻĻ āϤāĻĨā§āϝāĻžāĻŦāϞ⧀āĨ¤QR Code ...
03/07/2025

āĻŦāĻžāĻ‚āϞāĻžāĻĻ⧇āĻļ āĻĢāĻžāĻ°ā§āĻŽā§‡āϏ⧀ āĻ•āĻžāωāĻ¨ā§āϏāĻŋāϞ⧇āϰ 'āĻ', 'āĻŦāĻŋ' āĻāĻŦāĻ‚ 'āϏāĻŋ' āĻ•ā§āϝāĻžāϟāĻžāĻ—āϰāĻŋāϰ āϰ⧇āϜāĻŋāĻ¸ā§āĻŸā§āϰ⧇āĻļāύ āϏāĻ‚āĻ•ā§āϰāĻžāĻ¨ā§āϤ āĻ•āĻžāĻ°ā§āϝāĻ•ā§āϰāĻŽā§‡āϰ āĻšāĻžāϞāύāĻžāĻ—āĻžāĻĻ āϤāĻĨā§āϝāĻžāĻŦāϞ⧀āĨ¤

QR Code āϏāĻŽā§āĻŦāϞāĻŋāϤ 'āĻ', 'āĻŦāĻŋ' āĻāĻŦāĻ‚ 'āϏāĻŋ' āĻ•ā§āϝāĻžāϟāĻžāĻ—āϰāĻŋāϰ āϰ⧇āϜāĻŋāĻ¸ā§āĻŸā§āϰ⧇āĻļāύ āϏāύāĻĻ āĻ…āύāϞāĻžāχāύ⧇ āĻĒā§āϰāĻĻāĻžāύ āĻ•āϰāĻž āĻšāĻŦ⧇;

(⧍) āϰ⧇āϜāĻŋāĻ¸ā§āĻŸā§āϰ⧇āĻļāύ āϏāύāĻĻ āύāĻŦāĻžā§Ÿāύ⧇āϰ āĻ•ā§āώ⧇āĻ¤ā§āϰ⧇ āχāϤāσāĻĒā§‚āĻ°ā§āĻŦ⧇ āχāĻ¸ā§āϝ⧁āĻ•ā§ƒāϤ 'āĻ', 'āĻŦāĻŋ' āĻāĻŦāĻ‚ 'āϏāĻŋ' āĻ•ā§āϝāĻžāϟāĻžāĻ—āϰāĻŋāϰ āϰ⧇āϜāĻŋāĻ¸ā§āĻŸā§āϰ⧇āĻļāύ āϏāύāĻĻ⧇āϰ āĻšāĻžāĻ°ā§āĻĄ āĻ•āĻĒāĻŋ āĻ•āĻžāωāĻ¨ā§āϏāĻŋāϞ⧇ āϏāĻŽāĻ°ā§āĻĒāϪ⧇āϰ āĻĒāϰ āύāĻŦāĻžā§ŸāύāĻĒā§‚āĻ°ā§āĻŦāĻ• āĻ…āύāϞāĻžāχāύ⧇ QR Code āϏāĻŽā§āĻŦāϞāĻŋāϤ 'āĻ', 'āĻŦāĻŋ' āĻāĻŦāĻ‚ 'āϏāĻŋ' āĻ•ā§āϝāĻžāϟāĻžāĻ—āϰāĻŋāϰ āϰ⧇āϜāĻŋāĻ¸ā§āĻŸā§āϰ⧇āĻļāύ āϏāύāĻĻ āĻĒā§āϰāĻĻāĻžāύ āĻ•āϰāĻž āĻšāĻŦ⧇;

(ā§Š) 'āĻ', 'āĻŦāĻŋ' āĻāĻŦāĻ‚ 'āϏāĻŋ' āĻ•ā§āϝāĻžāϟāĻžāĻ—āϰāĻŋāϰ āϰ⧇āϜāĻŋāĻ¸ā§āĻŸā§āϰ⧇āĻļāύ āφāĻŦ⧇āĻĻāύ⧇āϰ āĻ•ā§āώ⧇āĻ¤ā§āϰ⧇ āϜāĻžāĻ¤ā§€ā§Ÿ āĻĒāϰāĻŋāϚ⧟āĻĒāĻ¤ā§āϰ āĻŦāĻžāĻ§ā§āϝāϤāĻžāĻŽā§‚āϞāĻ• āĻ•āϰāĻž āĻšā§Ÿā§‡āϛ⧇;

(ā§Ē) āĻ¸ā§āĻŽāĻžāĻ°ā§āϟ āϰ⧇āϜāĻŋāĻ¸ā§āĻŸā§āϰ⧇āĻļāύ āĻ•āĻžāĻ°ā§āĻĄ āĻ—ā§āϰāĻšāϪ⧇ āφāĻ—ā§āϰāĻšā§€ āϰ⧇āϜāĻŋāĻ¸ā§āĻŸā§āϰ⧇āĻļāύ āϏāύāĻĻāĻĒā§āϰāĻžāĻĒā§āϤ āĻŦā§āϝāĻ•ā§āϤāĻŋāϰ āφāĻŦ⧇āĻĻāύ⧇āϰ āĻĒāϰāĻŋāĻĒā§āϰ⧇āĻ•ā§āώāĻŋāϤ⧇ ā§Ģā§Ļā§Ļ (āĻĒāĻžāρāϚāĻļāϤ) āϟāĻžāĻ•āĻž āĻĢāĻŋ āĻĒā§āϰāĻĻāĻžāύ āϏāĻžāĻĒ⧇āĻ•ā§āώ⧇ āĻ¸ā§āĻŽāĻžāĻ°ā§āϟ āϰ⧇āϜāĻŋāĻ¸ā§āĻŸā§āϰ⧇āĻļāύ āĻ•āĻžāĻ°ā§āĻĄ āχāĻ¸ā§āϝ⧁ āĻ•āϰāĻž āĻšāĻŦ⧇;

(ā§Ģ) 'āĻ', 'āĻŦāĻŋ' āĻāĻŦāĻ‚ 'āϏāĻŋ' āĻ•ā§āϝāĻžāϟāĻžāĻ—āϰāĻŋāϰ āϰ⧇āϜāĻŋāĻ¸ā§āĻŸā§āϰ⧇āĻļāύ⧇āϰ āφāĻŦ⧇āĻĻāύ āĻ“ āύāĻŦāĻžā§Ÿāύ⧇āϰ āφāĻŦ⧇āĻĻāύ⧇āϰ āĻ•ā§āώ⧇āĻ¤ā§āϰ⧇ āĻ•ā§āώāĻŽāϤāĻž āĻšāĻ¸ā§āϤāĻžāĻ¨ā§āϤāϰāĻĒāĻ¤ā§āϰ (Authorization Letter) āĻ—ā§āϰāĻšāĻŖāϝ⧋āĻ—ā§āϝ āύ⧟ āĻāĻŦāĻ‚

āĻŦāĻŋāĻ¸ā§āϤāĻžāϰāĻŋāϤāσ https://shorturl.at/lHxIt



⧍ā§Ļ⧍ā§Ģ āϏāĻžāϞ⧇ āĻŦāĻŋāĻœā§āĻžāĻžāύ⧀āϰāĻž āĻŽāĻžāύāĻŦāĻĻ⧇āĻšā§‡ āĻāĻ•āϟāĻŋ āĻāϕ⧇āĻŦāĻžāϰ⧇ āύāϤ⧁āύ āϰāĻ•ā§āϤ⧇āϰ āĻ—ā§āϰ⧁āĻĒ āϏāĻŋāĻ¸ā§āĻŸā§‡āĻŽ āφāĻŦāĻŋāĻˇā§āĻ•āĻžāϰ āĻ•āϰ⧇āύ, āϝāĻžāϰ āύāĻžāĻŽ “Gwada Negative”āĨ¤ āĻāχ āϰāĻ•ā§āϤāĻ—ā§āϰ...
30/06/2025

⧍ā§Ļ⧍ā§Ģ āϏāĻžāϞ⧇ āĻŦāĻŋāĻœā§āĻžāĻžāύ⧀āϰāĻž āĻŽāĻžāύāĻŦāĻĻ⧇āĻšā§‡ āĻāĻ•āϟāĻŋ āĻāϕ⧇āĻŦāĻžāϰ⧇ āύāϤ⧁āύ āϰāĻ•ā§āϤ⧇āϰ āĻ—ā§āϰ⧁āĻĒ āϏāĻŋāĻ¸ā§āĻŸā§‡āĻŽ āφāĻŦāĻŋāĻˇā§āĻ•āĻžāϰ āĻ•āϰ⧇āύ, āϝāĻžāϰ āύāĻžāĻŽ “Gwada Negative”āĨ¤ āĻāχ āϰāĻ•ā§āϤāĻ—ā§āϰ⧁āĻĒāϟāĻŋ āĻāϤāϟāĻžāχ āĻŦāĻŋāϰāϞ āϝ⧇ āĻĒ⧃āĻĨāĻŋāĻŦā§€āϰ ā§Žā§Ļā§Ļ āϕ⧋āϟāĻŋ āĻŽāĻžāύ⧁āώ⧇āϰ āĻŽāĻ§ā§āϝ⧇ āĻāĻ–āύ āĻĒāĻ°ā§āϝāĻ¨ā§āϤ āĻļ⧁āϧ⧁āĻŽāĻžāĻ¤ā§āϰ āĻāĻ•āϜāύ āĻŽāĻžāύ⧁āώ⧇āϰ āĻļāϰ⧀āϰ⧇āχ āĻāϟāĻŋ āĻĒāĻžāĻ“ā§ŸāĻž āϗ⧇āϛ⧇āĨ¤

⧍ā§Ļā§§ā§§ āϏāĻžāϞ⧇, āĻĢā§āϰāĻžāĻ¨ā§āϏ⧇āϰ āĻ—ā§āϝ⧁⧟āĻžāĻĄā§‡āϞ⧁āĻĒ āĻĻā§āĻŦā§€āĻĒ (Guadeloupe) āĻ…āĻžā§āϚāϞ⧇āϰ āĻāĻ• ā§Ŧā§Ž āĻŦāĻ›āϰ āĻŦ⧟āϏ⧀ āύāĻžāϰ⧀āϰ āϰāĻ•ā§āϤ āĻĒāϰ⧀āĻ•ā§āώāĻž āϚāϞāĻžāĻ•āĻžāϞ⧀āύ āĻĄāĻžāĻ•ā§āϤāĻžāϰāϰāĻž āĻāĻ• āĻ…āϜāĻžāύāĻž āĻ…ā§āϝāĻžāĻ¨ā§āϟāĻŋāĻŦāĻĄāĻŋ āϞāĻ•ā§āĻˇā§āϝ āĻ•āϰ⧇āύāĨ¤

āĻ…ā§āϝāĻžāĻ¨ā§āϟāĻŋāĻŦāĻĄāĻŋāϟāĻŋ āϕ⧋āύ⧋ āĻŦāĻŋāĻĻā§āϝāĻŽāĻžāύ āϰāĻ•ā§āϤ āĻ—ā§āϰ⧁āĻĒ āϏāĻŋāĻ¸ā§āĻŸā§‡āĻŽā§‡āϰ āϏāĻ™ā§āϗ⧇ āĻŽā§‡āϞ⧇āύāĻŋāĨ¤

āĻĒāϰāĻŦāĻ°ā§āϤ⧀ ā§§ā§Ļ āĻŦāĻ›āϰ āϧāϰ⧇ DNA sequencing āĻāĻŦāĻ‚ āϰāĻ•ā§āϤ āĻŦāĻŋāĻļā§āϞ⧇āώāϪ⧇āϰ āĻĒāϰ āύāĻŋāĻļā§āϚāĻŋāϤ āĻšāĻ“ā§ŸāĻž āϝāĻžā§Ÿ āϝ⧇ āĻāϟāĻŋ āĻāĻ•āϟāĻŋ āϏāĻŽā§āĻĒā§‚āĻ°ā§āĻŖ āύāϤ⧁āύ āϰāĻ•ā§āϤ āĻ—ā§āϰ⧁āĻĒ āϏāĻŋāĻ¸ā§āĻŸā§‡āĻŽāĨ¤

“Gwada” āĻļāĻŦā§āĻĻāϟāĻŋ āĻāϏ⧇āϛ⧇ Guadeloupe āĻ…āĻžā§āϚāϞ āĻĨ⧇āϕ⧇, āĻ•āĻžāϰāĻŖ āϏ⧇āĻ–āĻžāύ⧇āχ āĻĒā§āϰāĻĨāĻŽ āĻāϟāĻŋ āĻļāύāĻžāĻ•ā§āϤ āĻšā§ŸāĨ¤

“Negative” āĻ…āĻ‚āĻļāϟāĻŋ āĻŦā§‹āĻāĻžā§Ÿ āϝ⧇ āĻāχ āϰāĻ•ā§āϤāĻ—ā§āϰ⧁āĻĒ⧇āϰ āĻŽāĻžāύ⧁āώ āĻ…āĻ¨ā§āϝ āϏāĻžāϧāĻžāϰāĻŖ āϰāĻ•ā§āϤāĻ—ā§āϰ⧁āĻĒāϧāĻžāϰ⧀āĻĻ⧇āϰ āĻ•āĻžāĻ› āĻĨ⧇āϕ⧇ āϰāĻ•ā§āϤ āύāĻŋāϤ⧇ āĻĒāĻžāϰ⧇ āύāĻžāĨ¤ āĻ•āĻžāϰāĻŖ āĻāϰ āĻ…ā§āϝāĻžāĻ¨ā§āϟāĻŋāĻœā§‡āύāϗ⧁āϞ⧋ āĻāϕ⧇āĻŦāĻžāϰ⧇ āĻ…āύāĻ¨ā§āϝāĨ¤

ISBT (International Society of Blood Transfusion) āĻāχ āϰāĻ•ā§āϤāĻ—ā§āϰ⧁āĻĒāϕ⧇ ā§Ēā§ŽāϤāĻŽ āϰāĻ•ā§āϤāĻ—ā§āϰ⧁āĻĒ āϏāĻŋāĻ¸ā§āĻŸā§‡āĻŽ āĻšāĻŋāϏ⧇āĻŦ⧇ āĻ¸ā§āĻŦā§€āĻ•ā§ƒāϤāĻŋ āĻĻā§‡ā§ŸāĨ¤

āĻāχ āϏāĻŋāĻ¸ā§āĻŸā§‡āĻŽā§‡āϰ āĻŽāĻ§ā§āϝ⧇ āĻāĻŽāύ āĻāĻ•āϧāϰāύ⧇āϰ āĻ…ā§āϝāĻžāĻ¨ā§āϟāĻŋāĻœā§‡āύ āĻŽāĻŋāωāĻŸā§‡āĻļāύ āĻ°ā§Ÿā§‡āϛ⧇ āϝāĻž āĻ…āĻ¨ā§āϝ āϕ⧋āύ⧋ āϰāĻ•ā§āϤāĻ—ā§āϰ⧁āĻĒ⧇ āύ⧇āχāĨ¤

āĻāχ āϰāĻ•ā§āϤ āĻļ⧁āϧ⧁ āύāĻŋāĻœā§‡āχ āύāĻŋāĻœā§‡āϕ⧇ āĻĻāĻŋāϤ⧇ āĻŦāĻž āύāĻŋāϤ⧇ āĻĒāĻžāϰ⧇ — āĻ…āĻ°ā§āĻĨāĻžā§Ž compatible only with selfāĨ¤

āĻāχ āύāĻžāϰ⧀āϰ āϰāĻ•ā§āϤ⧇ āĻŦāĻŋāĻļā§āĻŦ⧇āϰ āĻ…āĻ¨ā§āϝ āϕ⧋āύ⧋ āĻŽāĻžāύ⧁āώ⧇āϰ āϰāĻ•ā§āϤ āĻŽā§‡āϞāĻžāύ⧋ āϏāĻŽā§āĻ­āĻŦ āύ⧟āĨ¤

āϤāĻžāϰ āϜāĻ¨ā§āϝ āϰāĻ•ā§āϤ⧇āϰ āϏāĻ‚āĻ•āϟ āĻšāϞ⧇, āĻ…āĻ¨ā§āϝ āϕ⧋āύ⧋ āϰāĻ•ā§āϤ āĻĻ⧇āĻ“ā§ŸāĻžāϰ āϏ⧁āϝ⧋āĻ— āύ⧇āχāĨ¤ āĻļ⧁āϧ⧁āĻŽāĻžāĻ¤ā§āϰ āφāϗ⧇ āĻĨ⧇āϕ⧇ āϏāĻ‚āϰāĻ•ā§āώāĻŋāϤ āύāĻŋāĻœā§‡āϰ āϰāĻ•ā§āϤāχ āĻĻ⧇āĻ“ā§ŸāĻž āϝāĻžāĻŦ⧇āĨ¤

āĻĻ⧇āĻ–āĻžā§Ÿ āϝ⧇ āĻāĻ–āύ⧋ āφāĻŽāϰāĻž āĻŽāĻžāύāĻŦāĻĻ⧇āĻš āĻāĻŦāĻ‚ āϜāĻŋāύāĻ—āϤ āĻŦ⧈āϚāĻŋāĻ¤ā§āĻ°ā§āϝ āϏāĻŽā§āĻĒāĻ°ā§āϕ⧇ āĻ…āύ⧇āĻ• āĻ•āĻŋāϛ⧁ āϜāĻžāύāĻŋ āύāĻžāĨ¤

āĻāχ āϧāϰāύ⧇āϰ āφāĻŦāĻŋāĻˇā§āĻ•āĻžāϰ āϰāĻ•ā§āϤāĻĻāĻžāύ, āĻŸā§āϰāĻžāĻ¨ā§āϏāĻĢāĻŋāωāĻļāύ āϏāĻŋāĻ¸ā§āĻŸā§‡āĻŽ āĻāĻŦāĻ‚ āĻ…āĻ°ā§āĻ—āĻžāύ āĻŸā§āϰāĻžāĻ¨ā§āϏāĻĒā§āĻ˛ā§āϝāĻžāĻ¨ā§āĻŸā§‡ āĻŦāĻŋāĻĒā§āϞāĻŦ āϘāϟāĻžāϤ⧇ āĻĒāĻžāϰ⧇āĨ¤

āĻŦāĻŋāϰāϞ āϰāĻ•ā§āϤāĻ—ā§āϰ⧁āĻĒ⧇āϰ āĻŦā§āϝāĻ•ā§āϤāĻŋāĻĻ⧇āϰ āϜāĻ¨ā§āϝ āĻŦāĻŋāĻļ⧇āώāĻžā§ŸāĻŋāϤ āϰāĻ•ā§āϤāĻŦā§āϝāĻžāĻ‚āĻ• āĻ“ āĻĄā§‡āϟāĻžāĻŦ⧇āϏ āϤ⧈āϰāĻŋāϰ āĻĒā§āĻ°ā§Ÿā§‹āϜāĻ¨ā§€ā§ŸāϤāĻžāĻ“ āĻŦā§‹āĻāĻžā§ŸāĨ¤

⧍ā§Ļ⧍ā§Ģ āϏāĻžāϞ⧇āϰ āϜ⧁āύ āĻŽāĻžāϏ⧇, ISBT āĻāχ āϰāĻ•ā§āϤāĻ—ā§āϰ⧁āĻĒāϕ⧇ "Gwada Negative" āύāĻžāĻŽā§‡ āĻ¸ā§āĻŦā§€āĻ•ā§ƒāϤāĻŋ āĻĻā§‡ā§ŸāĨ¤

āĻāϰ āĻŽāĻžāĻ§ā§āϝāĻŽā§‡ āĻāϟāĻŋ āĻŦāĻŋāĻļā§āĻŦ⧇āϰ ā§Ēā§ŽāϤāĻŽ āϰāĻ•ā§āϤāĻ—ā§āϰ⧁āĻĒ āϏāĻŋāĻ¸ā§āĻŸā§‡āĻŽ āĻšāĻŋāϏ⧇āĻŦ⧇ āϜāĻžā§ŸāĻ—āĻž āĻ•āϰ⧇ āĻ¨ā§‡ā§ŸāĨ¤

Gwada Negative āφāĻŽāĻžāĻĻ⧇āϰ āĻļ⧇āĻ–āĻžā§Ÿ — āĻŽāĻžāύāĻŦāĻĻ⧇āĻšā§‡āϰ āĻ—āĻ­ā§€āϰ⧇ āĻāĻ–āύ⧋ āĻ…āϏāĻ‚āĻ–ā§āϝ āϰāĻšāĻ¸ā§āϝ āĻ°ā§Ÿā§‡ āϗ⧇āϛ⧇āĨ¤ āĻāχ āϰāĻ•ā§āϤāĻ—ā§āϰ⧁āĻĒ āĻāĻ•āĻĻāĻŋāϕ⧇ āϝ⧇āĻŽāύ āĻŦāĻŋāϰāϞ, āϤ⧇āĻŽāύāĻŋ āĻœā§‡āύ⧇āϟāĻŋāĻ• āĻāĻŦāĻ‚ āϚāĻŋāĻ•āĻŋā§ŽāϏāĻžāĻŦāĻŋāĻœā§āĻžāĻžāύ⧇ āύāϤ⧁āύ āϏāĻŽā§āĻ­āĻžāĻŦāύāĻžāϰ āĻĻāϰāϜāĻž āϖ⧁āϞ⧇ āĻĻāĻŋā§Ÿā§‡āϛ⧇āĨ¤

"China Plus One" āĻ¸ā§āĻŸā§āĻ°ā§āϝāĻžāĻŸā§‡āϜāĻŋ: āĻŦāĻŋāĻļā§āĻŦ āĻŦāĻžāĻŖāĻŋāĻœā§āϝ⧇ āύāϤ⧁āύ āĻŽā§‡āϰ⧁āĻ•āϰāĻŖ āĻāĻŦāĻ‚ āĻŦāĻžāĻ‚āϞāĻžāĻĻ⧇āĻļ⧇āϰ āϏāĻŽā§āĻ­āĻžāĻŦāύāĻžāĻŦāĻŋāĻ—āϤ āĻ•āϝāĻŧ⧇āĻ• āĻĻāĻļāĻ• āϧāϰ⧇ āĻŦāĻŋāĻļā§āĻŦ āĻ…āĻ°ā§āĻĨāύ⧀āϤāĻŋāϤ⧇ "āĻŽ...
29/06/2025

"China Plus One" āĻ¸ā§āĻŸā§āĻ°ā§āϝāĻžāĻŸā§‡āϜāĻŋ: āĻŦāĻŋāĻļā§āĻŦ āĻŦāĻžāĻŖāĻŋāĻœā§āϝ⧇ āύāϤ⧁āύ āĻŽā§‡āϰ⧁āĻ•āϰāĻŖ āĻāĻŦāĻ‚ āĻŦāĻžāĻ‚āϞāĻžāĻĻ⧇āĻļ⧇āϰ āϏāĻŽā§āĻ­āĻžāĻŦāύāĻž
āĻŦāĻŋāĻ—āϤ āĻ•āϝāĻŧ⧇āĻ• āĻĻāĻļāĻ• āϧāϰ⧇ āĻŦāĻŋāĻļā§āĻŦ āĻ…āĻ°ā§āĻĨāύ⧀āϤāĻŋāϤ⧇ "āĻŽā§‡āχāĻĄ āχāύ āϚāĻžāϝāĻŧāύāĻž" āĻŸā§āϝāĻžāĻ—āϟāĻŋ āĻ›āĻŋāϞ āĻāĻ• āĻ…āĻĒā§āϰāϤāĻŋāϰ⧋āĻ§ā§āϝ āĻŦāĻžāĻ¸ā§āϤāĻŦāϤāĻžāĨ¤ āϏāĻ¸ā§āϤāĻž āĻļā§āϰāĻŽ āĻāĻŦāĻ‚ āĻŦāĻŋāĻļāĻžāϞ āĻ‰ā§ŽāĻĒāĻžāĻĻāύ āĻ•ā§āώāĻŽāϤāĻžāϰ āĻ“āĻĒāϰ āĻ­āϰ āĻ•āϰ⧇ āĻšā§€āύ āĻŦāĻŋāĻļā§āĻŦ⧇āϰ āĻ•āĻžāϰāĻ–āĻžāύāĻžāϝāĻŧ (World's Factory) āĻĒāϰāĻŋāĻŖāϤ āĻšāϝāĻŧ⧇āĻ›āĻŋāϞāĨ¤ āĻ•āĻŋāĻ¨ā§āϤ⧁ āϏāĻžāĻŽā§āĻĒā§āϰāϤāĻŋāĻ• āĻŦāĻ›āϰāϗ⧁āϞ⧋āϤ⧇ āĻ­ā§‚-āϰāĻžāϜāύ⧈āϤāĻŋāĻ• āωāĻ¤ā§āϤ⧇āϜāύāĻž, āĻŦāĻžāĻŖāĻŋāĻœā§āϝ āϝ⧁āĻĻā§āϧ āĻāĻŦāĻ‚ āϕ⧋āĻ­āĻŋāĻĄ-⧧⧝ āĻŽāĻšāĻžāĻŽāĻžāϰāĻŋāϰ āĻŽāϤ⧋ āϘāϟāύāĻžāϗ⧁āϞ⧋ āĻŦāĻŋāĻļā§āĻŦāϜ⧁āĻĄāĻŧ⧇ āϕ⧋āĻŽā§āĻĒāĻžāύāĻŋāϗ⧁āϞ⧋āϕ⧇ āϤāĻžāĻĻ⧇āϰ āĻ‰ā§ŽāĻĒāĻžāĻĻāύ āĻāĻŦāĻ‚ āϏāĻžāĻĒā§āϞāĻžāχ āĻšā§‡āχāύ āύāĻŋāϝāĻŧ⧇ āύāϤ⧁āύ āĻ•āϰ⧇ āĻ­āĻžāĻŦāϤ⧇ āĻŦāĻžāĻ§ā§āϝ āĻ•āϰ⧇āϛ⧇āĨ¤ āĻāχ āύāϤ⧁āύ āĻ­āĻžāĻŦāύāĻž āĻĨ⧇āϕ⧇āχ āϜāĻ¨ā§āĻŽ āύāĻŋāϝāĻŧ⧇āϛ⧇ āĻāĻ• āĻ•ā§ŒāĻļāϞ, āϝāĻž "China Plus One" āĻ¸ā§āĻŸā§āĻ°ā§āϝāĻžāĻŸā§‡āϜāĻŋ āύāĻžāĻŽā§‡ āĻĒāϰāĻŋāϚāĻŋāϤāĨ¤

"China Plus One" āĻ¸ā§āĻŸā§āĻ°ā§āϝāĻžāĻŸā§‡āϜāĻŋ āϕ⧀?
"China Plus One" (āϏāĻ‚āĻ•ā§āώ⧇āĻĒ⧇ C+1) āĻšāϞ⧋ āĻāĻ•āϟāĻŋ āĻŦā§āϝāĻŦāϏāĻžāϝāĻŧāĻŋāĻ• āĻ•ā§ŒāĻļāϞ, āϝ⧇āĻ–āĻžāύ⧇ āφāĻ¨ā§āϤāĻ°ā§āϜāĻžāϤāĻŋāĻ• āϕ⧋āĻŽā§āĻĒāĻžāύāĻŋāϗ⧁āϞ⧋ āĻļ⧁āϧ⧁āĻŽāĻžāĻ¤ā§āϰ āĻšā§€āύ⧇āϰ āĻ“āĻĒāϰ āϤāĻžāĻĻ⧇āϰ āĻ‰ā§ŽāĻĒāĻžāĻĻāύ āĻŦāĻž āϏ⧋āĻ°ā§āϏāĻŋāĻ‚-āĻāϰ āϜāĻ¨ā§āϝ āύāĻŋāĻ°ā§āĻ­āϰāĻļā§€āϞ āύāĻž āĻĨ⧇āϕ⧇, āĻšā§€āύ⧇āϰ āĻĒāĻžāĻļāĻžāĻĒāĻžāĻļāĻŋ āĻ…āĻ¨ā§āϝ āĻāĻ• āĻŦāĻž āĻāĻ•āĻžāϧāĻŋāĻ• āĻĻ⧇āĻļ⧇ āϤāĻžāĻĻ⧇āϰ āĻ•āĻžāĻ°ā§āϝāĻ•ā§āϰāĻŽ āϏāĻŽā§āĻĒā§āϰāϏāĻžāϰāĻŖ āĻ•āϰ⧇āĨ¤ āĻāϰ āĻŽā§‚āϞ āωāĻĻā§āĻĻ⧇āĻļā§āϝ āĻšā§€āύ⧇āϰ āĻ“āĻĒāϰ āĻāĻ•āĻ• āύāĻŋāĻ°ā§āĻ­āϰāĻļā§€āϞāϤāĻžāϰ āĻā§āρāĻ•āĻŋ āĻ•āĻŽāĻžāύ⧋ (De-risking) āĻāĻŦāĻ‚ āĻāĻ•āϟāĻŋ āĻ¸ā§āĻĨāĻŋāϤāĻŋāĻļā§€āϞ āĻ“ āĻŦ⧈āϚāĻŋāĻ¤ā§āĻ°ā§āϝāĻŽāϝāĻŧ āϏāĻžāĻĒā§āϞāĻžāχ āĻšā§‡āχāύ āϤ⧈āϰāĻŋ āĻ•āϰāĻžāĨ¤

āĻāϰ āĻŽāĻžāύ⧇ āĻāχ āύāϝāĻŧ āϝ⧇ āϕ⧋āĻŽā§āĻĒāĻžāύāĻŋāϗ⧁āϞ⧋ āĻšā§€āύ āĻĨ⧇āϕ⧇ āĻĒ⧁āϰ⧋āĻĒ⧁āϰāĻŋ āĻŦā§āϝāĻŦāϏāĻž āϗ⧁āϟāĻŋāϝāĻŧ⧇ āύāĻŋāĻšā§āϛ⧇āĨ¤ āĻŦāϰāĻ‚, āϤāĻžāϰāĻž āĻšā§€āύ⧇ āϤāĻžāĻĻ⧇āϰ āĻ•āĻžāĻ°ā§āϝāĻ•ā§āϰāĻŽ āĻŦāϜāĻžāϝāĻŧ āϰ⧇āϖ⧇ āĻŦāĻŋāĻ•āĻ˛ā§āĻĒ āĻ‰ā§ŽāĻĒāĻžāĻĻāύ āϕ⧇āĻ¨ā§āĻĻā§āϰ āĻšāĻŋāϏ⧇āĻŦ⧇ āĻĻā§āĻŦāĻŋāϤ⧀āϝāĻŧ āφāϰ⧇āĻ•āϟāĻŋ āĻĻ⧇āĻļāϕ⧇ āĻŦ⧇āϛ⧇ āύāĻŋāĻšā§āϛ⧇āĨ¤

29/06/2025

āϛ⧁āϟāĻŋāϰ āĻĻāĻŋāύ⧇đŸŒŋ

āĻ”āώāϧ āĻĒā§āϰāĻļāĻžāϏāύ āĻ…āϧāĻŋāĻĻāĻĒā§āϤāϰ⧇āϰ  āĻĄā§āϰāĻžāĻ— āϞāĻžāχāϏ⧇āĻ¨ā§āϏ  āϏāĻ‚āĻ•ā§āϰāĻžāĻ¨ā§āϤ " āĻ—āĻŖāĻŦāĻŋāĻœā§āĻžāĻĒā§āϤāĻŋ" āĻāϤāĻĻā§āĻŦāĻžāϰāĻž āĻ”āώāϧ āĻŦā§āϝāĻŦāϏāĻžā§Ÿā§€āĻĻ⧇āϰ āϜāĻžāύāĻžāύ⧋ āϝāĻžāĻšā§āϛ⧇ āϝ⧇, āĻĢāĻžāĻ°ā§āĻŽā§‡āϏ⧀ āĻĒāϰāĻŋ...
19/06/2025

āĻ”āώāϧ āĻĒā§āϰāĻļāĻžāϏāύ āĻ…āϧāĻŋāĻĻāĻĒā§āϤāϰ⧇āϰ āĻĄā§āϰāĻžāĻ— āϞāĻžāχāϏ⧇āĻ¨ā§āϏ āϏāĻ‚āĻ•ā§āϰāĻžāĻ¨ā§āϤ
" āĻ—āĻŖāĻŦāĻŋāĻœā§āĻžāĻĒā§āϤāĻŋ"

āĻāϤāĻĻā§āĻŦāĻžāϰāĻž āĻ”āώāϧ āĻŦā§āϝāĻŦāϏāĻžā§Ÿā§€āĻĻ⧇āϰ āϜāĻžāύāĻžāύ⧋ āϝāĻžāĻšā§āϛ⧇ āϝ⧇, āĻĢāĻžāĻ°ā§āĻŽā§‡āϏ⧀ āĻĒāϰāĻŋāϚāĻžāϞāύāĻžāϰ āϜāĻ¨ā§āϝ āĻ”āώāϧ āĻĒā§āϰāĻļāĻžāϏāύ āĻ…āϧāĻŋāĻĻāĻĒā§āϤāϰ āĻšāϤ⧇ āĻĄā§āϰāĻžāĻ— āϞāĻžāχāϏ⧇āĻ¨ā§āϏ āĻ—ā§āϰāĻšāĻŖ āĻ•āϰāϤ⧇ āĻšā§Ÿ āĻāĻŦāĻ‚ āĻĒā§āϰāϤāĻŋ ā§Ļ⧍ (āĻĻ⧁āχ) āĻŦāĻ›āϰ āĻ…āĻ¨ā§āϤāϰ āĻ…āĻ¨ā§āϤāϰ āĻĄā§āϰāĻžāĻ— āϞāĻžāχāϏ⧇āĻ¨ā§āϏ āύāĻŦāĻžā§Ÿāύ āĻ•āϰāϤ⧇ āĻšā§ŸāĨ¤ āĻĄā§āϰāĻžāĻ— āϞāĻžāχāϏ⧇āĻ¨ā§āϏāĻŦāĻŋāĻšā§€āύ āĻĢāĻžāĻ°ā§āĻŽā§‡āϏ⧀ āĻĒāϰāĻŋāϚāĻžāϞāύāĻž āĻ•āϰāĻž 'āĻ”āώāϧ āĻ“ āĻ•āϏāĻŽā§‡āϟāĻŋāĻ•āĻ¸ā§ āφāχāύ-⧍ā§Ļā§¨ā§Š' āĻŽā§‹āϤāĻžāĻŦ⧇āĻ• āĻāĻ•āϟāĻŋ āĻļāĻžāĻ¸ā§āϤāĻŋāϝ⧋āĻ—ā§āϝ āĻ…āĻĒāϰāĻžāϧāĨ¤ āĻ…āύ⧇āĻ• āĻ”āώāϧ āĻŦā§āϝāĻŦāϏāĻžā§Ÿā§€āĻĻ⧇āϰ āĻĻ⧇āĻ–āĻž āϝāĻžāĻšā§āϛ⧇ āĻŦāĻšā§āĻĻāĻŋāύ āϝāĻžāĻŦā§Ž āĻĄā§āϰāĻžāĻ— āϞāĻžāχāϏ⧇āĻ¨ā§āϏ āύāĻŦāĻžā§Ÿāύ āĻŦā§āϝāϤāĻŋāϰ⧇āϕ⧇ āĻĢāĻžāĻ°ā§āĻŽā§‡āϏ⧀ āĻŦā§āϝāĻŦāϏāĻž āĻĒāϰāĻŋāϚāĻžāϞāύāĻž āĻ•āϰāϛ⧇āύāĨ¤

āĻāĻŽāϤāĻžāĻŦāĻ¸ā§āĻĨāĻžā§Ÿ, ā§Ļ⧍ (āĻĻ⧁āχ) āĻŽā§‡ā§ŸāĻžāĻĻ⧇āϰ āĻŦ⧇āĻļā§€ āĻĄā§āϰāĻžāĻ— āϞāĻžāχāϏ⧇āĻ¨ā§āϏ āύāĻŦāĻžā§Ÿāύ āύāĻž āĻ•āϰāĻž āĻĨāĻžāĻ•āϞ⧇ āϏāĻ‚āĻļā§āϞāĻŋāĻˇā§āϟ āĻœā§‡āϞāĻž āĻ•āĻžāĻ°ā§āϝāĻžāϞ⧟ āĻšāϤ⧇ ā§Šā§Ļ (āĻ¤ā§āϰāĻŋāĻļ) āĻĻāĻŋāύ⧇āϰ āĻŽāĻ§ā§āϝ⧇ āĻĄā§āϰāĻžāĻ— āϞāĻžāχāϏ⧇āĻ¨ā§āϏ āύāĻŦāĻžā§Ÿāύ āĻ•āϰāϤ⧇ āĻšāĻŦ⧇āĨ¤ āĻ…āĻ¨ā§āϝāĻĨāĻžā§Ÿ, ā§Šā§Ļ (āĻ¤ā§āϰāĻŋāĻļ) āĻĻāĻŋāύ āĻĒāϰ āĻšāϤ⧇ āφāχāύāĻ—āϤ āĻŦā§āϝāĻŦāĻ¸ā§āĻĨāĻž āĻ—ā§āϰāĻšāĻŖ āĻ•āϰāĻž āĻšāĻŦ⧇āĨ¤

āϖ⧁āϚāϰāĻž āĻĄā§āϰāĻžāĻ— āϞāĻžāχāϏ⧇āĻ¨ā§āϏ āύāĻŦāĻžā§Ÿāύ⧇āϰ āϜāĻ¨ā§āϝ āĻĒā§āĻ°ā§Ÿā§‹āϜāĻ¨ā§€ā§Ÿ āĻ•āĻžāĻ—āϜāĻĒāĻ¤ā§āϰāĻžāĻĻāĻŋ:

ā§§āĨ¤ āϝāĻĨāĻžāϝāĻĨāĻ­āĻžāĻŦ⧇ āĻĒā§‚āϰāĻŖāĻ•ā§ƒāϤ āĻĻāϰāĻ–āĻžāĻ¸ā§āϤ āĻĢāϰāĻŽ āύāĻ‚-ā§­āĨ¤

⧍āĨ¤āύāĻŋā§Ÿā§‹āϜāĻŋāϤ āĻĢāĻžāĻ°ā§āĻŽāĻžāϏāĻŋāĻ¸ā§āϟ/āĻ•āĻŦāĻŋāϰāĻžāϜ/āĻšāĻžāĻ•āĻŋāĻŽ/āĻšā§‹āĻŽāĻŋāĻ“ āĻĄāĻžāĻ•ā§āϤāĻžāϰ āĻāϰ āϰ⧇āϜāĻŋāĻ¸ā§āĻŸā§āϰ⧇āĻļāύ āϏāύāĻĻ⧇āϰ āĻŽā§‚āϞ āĻ•āĻĒāĻŋ āĻ“ āϏāĻ¤ā§āϝāĻžā§ŸāĻŋāϤ āĻĢāĻŸā§‹āĻ•āĻĒāĻŋāĨ¤

ā§ŠāĨ¤āύāĻŋā§Ÿā§‹āϜāĻŋāϤ āĻĢāĻžāĻ°ā§āĻŽāĻžāϏāĻŋāĻ¸ā§āϟ/āĻ•āĻŦāĻŋāϰāĻžāϜ/āĻšāĻžāĻ•āĻŋāĻŽ/āĻšā§‹āĻŽāĻŋāĻ“ āĻĄāĻžāĻ•ā§āϤāĻžāϰ āĻāϰ āĻ…āĻ™ā§āĻ—ā§€āĻ•āĻžāϰāύāĻžāĻŽāĻžāĨ¤

ā§ĒāĨ¤ āϞāĻžāχāϏ⧇āĻ¨ā§āϏ āύāĻŦāĻžā§Ÿāύ āĻĢāĻŋ āĻ“ āĻŦāĻŋāϞāĻŽā§āĻŦ āĻĢāĻŋ (āĻĒā§āϰāϝ⧋āĻœā§āϝ āĻ•ā§āώ⧇āĻ¤ā§āϰ⧇) āĻāϰ āĻŸā§āϰ⧇āϜāĻžāϰ⧀ āϚāĻžāϞāĻžāύ⧇āϰ āĻŽā§‚āϞ āĻ•āĻĒāĻŋāĨ¤

ā§ĢāĨ¤āĻĻā§‹āĻ•āĻžāύ⧇āϰ āĻšāĻžāϞāύāĻžāĻ—āĻžāĻĻ āĻŸā§āϰ⧇āĻĄ āϞāĻžāχāϏ⧇āĻ¨ā§āϏ-āĻāϰ āϏāĻ¤ā§āϝāĻžā§ŸāĻŋāϤ āĻĢāĻŸā§‹āĻ•āĻĒāĻŋāĨ¤

ā§ŦāĨ¤ āĻŽāĻžāϞāĻŋāϕ⧇āϰ āύāĻžāĻ—āϰāĻŋāĻ•āϤāĻžāϰ āϏāύāĻĻ⧇āϰ āϏāĻ¤ā§āϝāĻžā§ŸāĻŋāϤ āĻĢāĻŸā§‹āĻ•āĻĒāĻŋāĨ¤

ā§­āĨ¤ āĻĻā§‹āĻ•āĻžāύ āĻ­āĻžā§œāĻžāϰ āϚ⧁āĻ•ā§āϤāĻŋāύāĻžāĻŽāĻž/āĻ­āĻžā§œāĻžāϰ āϰāĻļāĻŋāĻĻ⧇āϰ āϏāĻ¤ā§āϝāĻžā§ŸāĻŋāϤ āĻĢāĻŸā§‹āĻ•āĻĒāĻŋāĨ¤

ā§ŽāĨ¤ āĻŽāĻžāϞāĻŋāϕ⧇āϰ āφāĻ°ā§āĻĨāĻŋāĻ• āĻ¸ā§āĻŦāĻšā§āĻ›āϞāϤāĻžāϰ āϏāύāĻĻ (āĻŦā§āϝāĻžāĻ‚āĻ• āϏāϞāϭ⧇āĻ¨ā§āϏāĻŋ āϏāĻžāĻ°ā§āϟāĻŋāĻĢāĻŋāϕ⧇āϟ)āĨ¤

⧝āĨ¤ Income Tax Return āϰāĻļāĻŋāĻĻ āĻāϰ āϏāĻ¤ā§āϝāĻžā§ŸāĻŋāϤ āĻĢāĻŸā§‹āĻ•āĻĒāĻŋāĨ¤

🔍 Internship Opportunity at Roche Bangladesh Ltd.🔹 Position: Business Support Intern🔹 Who Can Apply: Final-year students...
17/06/2025

🔍 Internship Opportunity at Roche Bangladesh Ltd.

🔹 Position: Business Support Intern
🔹 Who Can Apply: Final-year students or recent graduates (Pharmacy, BBA, Marketing, or related fields)
🔹 Location: Tejgaon-Gulshan Link Road, Dhaka

What You'll Do:
✅ Support event management, logistics, and approvals
✅ Assist in promotional material development
✅ Coordinate grants, sponsorships, and international congress activities
✅ Provide administrative and compliance support

Key Skills We Value:
âœ”ī¸ Strong organization & communication skills
âœ”ī¸ Detail-oriented with a proactive mindset
âœ”ī¸ Familiarity with MS Office; exposure to ROME, Veeva, or DocuSign is a plus

Whether you're a fresher or have 1–2 years of experience, this is your chance to learn, grow, and make an impact at a global healthcare leader.

https://careers.roche.com/global/en/job/202502-104140/Internship-Pharmaceutical-Business-Support-6-Months-Dhaka

OpprtunityđŸŒŋ
17/06/2025

OpprtunityđŸŒŋ

āĻ•ā§‹ā§ŸāĻžāϞāĻŋāϟāĻŋ āĻ•āĻ¨ā§āĻŸā§āϰ⧋āϞ (āĻ•āĻŋāω āϏāĻŋ) āĻ•ā§āϝāĻžāϰāĻŋ⧟āĻžāϰ āĻāĻ•ā§āϏāĻĒ⧇āϰāĻŋā§Ÿā§‡āĻ¨ā§āϏ!  🤔 āφāĻĒāύāĻžāϰ āĻ…āĻ­āĻŋāĻœā§āĻžāϤāĻž āĻ“ āĻŽāϤāĻžāĻŽāϤ āĻ•āĻŋ?
16/06/2025

āĻ•ā§‹ā§ŸāĻžāϞāĻŋāϟāĻŋ āĻ•āĻ¨ā§āĻŸā§āϰ⧋āϞ (āĻ•āĻŋāω āϏāĻŋ) āĻ•ā§āϝāĻžāϰāĻŋ⧟āĻžāϰ āĻāĻ•ā§āϏāĻĒ⧇āϰāĻŋā§Ÿā§‡āĻ¨ā§āϏ! 🤔 āφāĻĒāύāĻžāϰ āĻ…āĻ­āĻŋāĻœā§āĻžāϤāĻž āĻ“ āĻŽāϤāĻžāĻŽāϤ āĻ•āĻŋ?

Address

Tangail

Telephone

+8801766388247

Website

Alerts

Be the first to know and let us send you an email when Nazmul Islam Abir posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Nazmul Islam Abir:

Share